Karnes RJ - Search Results

1

Ki-67, topoisomerase IIα and miR-221 have a limited prostate cancer risk stratification ability on a medium-term follow-up: results of a high-risk radical prostatectomy cohort.

Marra G, Oderda M, Calleris G, Marquis A, Peretti F, Zitella A, Moschini M, Sanchez-Salas R, Karnes RJ, Kneitz B, Spahn M, Pacchioni D, Gontero P. Marra G, et al. Among authors: karnes rj. Transl Androl Urol. 2022 Sep;11(9):1271-1281. doi: 10.21037/tau-21-628. Transl Androl Urol. 2022. PMID: 36217395 Free PMC article.

2

Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era.

Boorjian SA, Thompson RH, Siddiqui S, Bagniewski S, Bergstralh EJ, Karnes RJ, Frank I, Blute ML. Boorjian SA, et al. Among authors: karnes rj. J Urol. 2007 Sep;178(3 Pt 1):864-70; discussion 870-1. doi: 10.1016/j.juro.2007.05.048. Epub 2007 Jul 16. J Urol. 2007. PMID: 17631342

3

Mayo Clinic validation of the D'amico risk group classification for predicting survival following radical prostatectomy.

Boorjian SA, Karnes RJ, Rangel LJ, Bergstralh EJ, Blute ML. Boorjian SA, et al. Among authors: karnes rj. J Urol. 2008 Apr;179(4):1354-60; discussion 1360-1. doi: 10.1016/j.juro.2007.11.061. Epub 2008 Mar 4. J Urol. 2008. PMID: 18289596

4

Radical retropubic prostatectomy in immunosuppressed transplant recipients.

Thompson RH, Leibovich BC, Karnes RJ, Bergstralh EJ, Blute ML. Thompson RH, et al. Among authors: karnes rj. J Urol. 2008 Apr;179(4):1349-52; discussion 1352-3. doi: 10.1016/j.juro.2007.11.054. Epub 2008 Mar 4. J Urol. 2008. PMID: 18289598

5

The impact of discordance between biopsy and pathological Gleason scores on survival after radical prostatectomy.

Boorjian SA, Karnes RJ, Crispen PL, Rangel LJ, Bergstralh EJ, Sebo TJ, Blute ML. Boorjian SA, et al. Among authors: karnes rj. J Urol. 2009 Jan;181(1):95-104; discussion 104. doi: 10.1016/j.juro.2008.09.016. Epub 2008 Nov 13. J Urol. 2009. PMID: 19012937

6

Radical prostatectomy for high-risk prostate cancer.

Karnes RJ, Hatano T, Blute ML, Myers RP. Karnes RJ, et al. Jpn J Clin Oncol. 2010 Jan;40(1):3-9. doi: 10.1093/jjco/hyp130. Epub 2009 Oct 19. Jpn J Clin Oncol. 2010. PMID: 19841101 Review.

7

The association between statin use and the diagnosis of prostate cancer in a population based cohort.

Breau RH, Karnes RJ, Jacobson DJ, McGree ME, Jacobsen SJ, Nehra A, Lieber MM, St Sauver JL. Breau RH, et al. Among authors: karnes rj. J Urol. 2010 Aug;184(2):494-9. doi: 10.1016/j.juro.2010.03.149. Epub 2010 Jun 17. J Urol. 2010. PMID: 20620405 Free PMC article.

8

Lifelong yearly prostate specific antigen surveillance is not necessary for low risk prostate cancer treated with radical prostatectomy.

Tollefson MK, Blute ML, Rangel LJ, Karnes RJ, Frank I. Tollefson MK, et al. Among authors: karnes rj. J Urol. 2010 Sep;184(3):925-9. doi: 10.1016/j.juro.2010.05.043. J Urol. 2010. PMID: 20643452

9

Serum calcium is not predictive of aggressive prostate cancer after radical prostatectomy.

Tollefson MK, Gettman MT, Blute ML, Bergstralh EJ, Rangel LJ, Karnes RJ. Tollefson MK, et al. Among authors: karnes rj. Urology. 2011 May;77(5):1161-5. doi: 10.1016/j.urology.2010.07.504. Epub 2010 Dec 3. Urology. 2011. PMID: 21122899

10

Long-term risk of clinical progression after biochemical recurrence following radical prostatectomy: the impact of time from surgery to recurrence.

Boorjian SA, Thompson RH, Tollefson MK, Rangel LJ, Bergstralh EJ, Blute ML, Karnes RJ. Boorjian SA, et al. Among authors: karnes rj. Eur Urol. 2011 Jun;59(6):893-9. doi: 10.1016/j.eururo.2011.02.026. Epub 2011 Feb 22. Eur Urol. 2011. PMID: 21388736

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

475 results

Search Page